ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2466

Increased Risk of Rheumatoid Arthritis (RA) Among Shared Epitope-Negative (SE-) Mothers with Shared Epitope-Positive (SE+) Children

Giovanna Cruz1, Lindsey A. Criswell2, Xiaorong Shao3, Hong L. Quach1, Janelle Noble4, Nikolaos Patsopoulos5, Michael Busch6 and Lisa F. Barcellos1, 1Epidemiology, University of California, Berkeley, Berkeley, CA, 2Medicine, University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, 3Genetic Epidemiology and Genomics Lab, Division of Epidemiology, University of California, Berkeley, Berkeley, CA, 4Children's Hospital Oakland Research Institute (CHORI), Oakland, CA, 5Division of Genetics, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, 6Blood Systems Research Institute, San Francisco, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, human leukocyte antigens (HLA), Immunogenetics, pregnancy and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose

RA (RA [MIM 180300]) disproportionately affects women of reproductive age, implicating pregnancy-related factors. Fetal microchimerism (FMC), or the persistence of a small population of cells in the mother, is a natural consequence of pregnancy. FMC is present more often in RA cases than in controls. Mother-child histocompatibility could determine long-term FMC, possibly increasing risk of RA through exposure to fetal HLA-antigens. We hypothesized that RA cases are more likely to have histocompatible (HC) children compared to controls. 

Methods

The MCIS included 5,000+ individuals; mothers with RA or SLE and controls (n=750), their children and fathers. RA cases with 1+ birth before diagnosis were recruited at UC San Francisco. Controls were primarily recruited from blood donors. Mothers provided information on their reproductive history, history of transfusion, transplant and infections. Comprehensive MHC region SNP genotyping was conducted using the Illumina MHC panel (n=1,783), ImmunoChip (n=8,842), and 660K (n=1,991) arrays. Four-digit genotype data for HLA-A, B, C, DPA1, DPB1, DQA1, DQB1 and DRB1 were imputed using the T1DGC reference panel and BEAGLE. We estimated ancestry proportions from 384 markers using STRUCTURE. A child was HC from the mother’s perspective if the paternal allele did not differ from the non-inherited maternal allele. Carrier status (+ or -) of any DRB1 allele associated with RA risk (Raychaudhuri, 2012) and corresponding to SE amino acid sequences QKRAA and QRRAA (01:01, 04:01, 04:04, 04:05, 04:08) and DERAA (01:03, 04:02, 11:02, 13:01, 13:02) was determined for mothers and children. We used logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the association between RA and a) HC at each HLA locus and b) exposure to any SE+ and DERAA+ children, stratifying on maternal carrier status.

Results

Increased HC among cases was only evident at DQB1 (25.3% vs. 17.4%, p=0.03). Having any SE+ children significantly increased risk of RA for SE- mothers (n=218) (OR 2.56; 95% CI, 1.43-4.58) but not SE+ mothers (n=248) (OR 1.48; 95% CI, 0.83-2.62). No association was found with DERAA+ children, regardless of maternal carrier status. Ancestry, parity, and history of transfusion did not impact results.

Conclusion

Exposure to SE+ children and DQB1 HC may contribute to RA etiology and could contribute to RA’s female-predominance. This is the largest study confirming the association between RA and SE+ children in SE- mothers.


Disclosure:

G. Cruz,
None;

L. A. Criswell,
None;

X. Shao,
None;

H. L. Quach,
None;

J. Noble,
None;

N. Patsopoulos,
None;

M. Busch,
None;

L. F. Barcellos,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-risk-of-rheumatoid-arthritis-ra-among-shared-epitope-negative-se-mothers-with-shared-epitope-positive-se-children/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology